Impact of anemia on short‐term outcomes after TAVR : A subgroup analysis from the BRAVO ‐3 randomized trial-Reference-Cited by-同舟云学术

Impact of anemia on short‐term outcomes after TAVR : A subgroup analysis from the BRAVO ‐3 randomized trial

Published:2021-05-12 Issue:6 Volume:98 Page:
ISSN:1522-1946
Container-title:Catheterization and Cardiovascular Interventions
language:en
Short-container-title:Cathet Cardio Intervent

Author:

Razuk Victor¹^ORCID,Camaj Anton¹,Cao Davide¹^ORCID,Nicolas Johny¹^ORCID,Hengstenberg Christian²,Sartori Samantha¹,Zhang Zhongjie¹,Power David¹,Beerkens Frans¹,Chiarito Mauro¹^ORCID,Meneveau Nicolas³,Tron Christophe⁴,Dumonteil Nicolas⁵,Widder Julian D.⁶,Ferrari Markus⁷,Violini Roberto⁸,Stella Pieter R.⁹,Jeger Raban¹⁰,Anthopoulos Prodromos¹¹,Mehran Roxana¹^ORCID,Dangas George D.¹^ORCID

Affiliation:

1. The Zena and Michael A. Wiener Cardiovascular Institute Icahn School of Medicine at Mount Sinai New York, New York USA

2. Department of Internal Medicine II, Division of Cardiology Medical University of Vienna Vienna Austria

3. Department of Cardiology University Hospital Jean Minjoz Besançon France

4. Division of Cardiology Rouen University Hospital Rouen France

5. Groupe CardioVasculaire Interventionnel Clinique Pasteur Toulouse France

6. Department of Cardiology and Angiology Hannover Medical School Hannover Germany

7. Interventional Cardiology Helios Dr. Horst Schmidt Kliniken Wiesbaden Wiesbaden Germany

8. Interventional Cardiology Unit San Camillo Hospital Rome Italy

9. Department of Cardiology University Medical Center Utrecht Utrecht the Netherlands

10. Department of Cardiology University Hospital Basel, University of Basel Switzerland

11. European Medical Arena Pharmaceuticals Inc Zurich Switzerland

Publisher

Wiley

Subject

Cardiology and Cardiovascular Medicine,Radiology, Nuclear Medicine and imaging,General Medicine

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/ccd.29753

Reference36 articles.

1. 2017 ESC/EACTS Guidelines for the management of valvular heart disease

2. 2017 AHA/ACC Focused Update of the 2014 AHA/ACC Guideline for the Management of Patients With Valvular Heart Disease: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines

3. 2020 ACC/AHA guideline for the Management of Patients with Valvular Heart Disease: executive summary: a report of the American College of Cardiology/American Heart Association joint committee on clinical practice guidelines;Otto CM;Circulation,2021

4. Two-Year Outcomes after Transcatheter or Surgical Aortic-Valve Replacement

5. Impact of diabetes mellitus on short term vascular complications after TAVR: Results from the BRAVO-3 randomized trial

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Implications of anemia in patients undergoing PCI with Impella-support: insights from the PROTECT III study;Frontiers in Cardiovascular Medicine;2024-07-18

2. Sedation with Ketamine-Propofol in Patients Undergoing Transcatheter Aortic Valve Implantation: A Comparative Retrospective Study on General Anesthesia;Current Vascular Pharmacology;2024-07

3. Impact of Baseline Anemia in Patients Undergoing Transcatheter Aortic Valve Replacement: A Prognostic Systematic Review and Meta-Analysis;Journal of Clinical Medicine;2023-09-18

4. Association between haematological parameters and outcomes following transcatheter aortic valve implantation at mid-term follow-up;Open Heart;2022-12